← Back to Clinical Trials
Recruiting NCT05974488

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Airway Obstruction
Sponsor University of Miami
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-11-30
Completion 2026-10-01
Interventions
McMurray Enhanced AirwayNasal Cannula

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.

Eligibility Criteria

Inclusion Criteria: * Age \> or = 18 years old * Patients willing to participate and provide an informed consent * Patients scheduled to undergo an elective TEE procedure. Exclusion Criteria: * Patients with history of uncontrolled gastroesophageal reflux disease * Patients with anatomical airway obstruction * Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE AIRWAY OBSTRUCTION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}